The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis

Clinical trial NCT05633563 · COMPLETED

Trial details

NCT number: NCT05633563
Sponsor: Steen Hvitfeldt Poulsen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiopathy Mitochondrial Pathology

Start date: 2021-10-01
Primary completion: 2023-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.